ENTITY

Oramed Pharmaceuticals (ORMP US)

10
Analysis
Health Care • Israel
Oramed Pharmaceuticals, Inc. is a pharmaceutical company focused on the development of oral delivery solution. The Company is developing orally ingestible insulin capsules for the treatment diabetes as well as delivery solutions for other drugs and vaccines.
more
•28 Aug 2026 22:00•Issuer-paid

ORMP: Investment Gains Contributed to Strong 2Q26 EPS

Several recent investment portfolio holdings have yielded strong returns and ORMP is optimistic about its ability to continue to create...

Share
•19 Jun 2026 01:00•Issuer-paid

ORMP: View ORMP Inclusion in Russell Indexes as Positive That Could Raise Awareness in Investment Community

We believe inclusion in these Russell indexes could raise awareness of Oramed within the investment community, which we view as a positive. In...

Share
•09 Jun 2026 02:00•Issuer-paid

ORMP: Strategically Acquiring Interests in Medtech & Technology Companies

ORMP, Corner Capital Management & investor Ben Shapiro have also launched the Corner Ally Ventures fund focused on investments in Israeli...

Share
•27 Feb 2026 06:00•Issuer-paid

ORMP: Enabling Participation in Both ORMP & LFWD Businesses Expected to Enhance Shareholder Value

ORMP expects to fund and manage an upcoming clinical trial that builds on earlier Phase 2 and Phase 3 trials it conducted. Separately, ORMP has...

Share
•25 Nov 2025 03:00•Issuer-paid

ORMP: Advancing Clinical Activities

ORMP is leveraging its strong balance sheet to invest in early stage companies, primarily focusing on the medical & biopharma space. ORMP has...

Share
x